<DOC>
	<DOCNO>NCT00197639</DOCNO>
	<brief_summary>This study look way indinavir drug level , boost ritonavir , may vary patient patient . The study population HIV+ Thai individual .</brief_summary>
	<brief_title>Pharmacokinetic Study Indinavir Drug Levels When Boosted With Ritonavir Thailand</brief_title>
	<detailed_description>This study assess inter-individual variability indinavir drug level , boost ritonavir , Thai patient . Data collect patient participate randomize study , `` Monitoring Highly Active Antiretroviral Therapy ( HAART ) HIV-infected patient Thailand ( PHPT-3 ) '' ( HSC 10668 ) . The first 20 patent PHPT-3 steady-state pharmacokinetic sparse sample perform pre-dose , 1 , 2.5 , 4 12 hour drug intake 1 2 month initiate IDV/r 400/100 mg , twice daily . IDV/r plasma concentration determine high performance liquid chromatography . This spare PK data pool indinavir concentration data collect within intensive pharmacokinetic study IDV/r [ Cressey TR , et al 2005 , JAC , 55 , p1041-44 ] . Population mean variance indinavir ritonavir pharmacokinetic parameter estimate use non-linear mixed effect regression model ( NONMEM Version VI ) . The validity final model evaluate use visual predictive check ( VPC ) bootstrap re-sampling technique .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Subjects enrol parent study , `` Monitoring HAART Therapy HIVInfected Patients Thailand ( PHPT3 ) '' agree additional blood sampling test . Current active substance alcohol abuse Active opportunistic infection Chronic malabsorption diarrhea Other clinically significant disease Certain lab value ( e.g . hemoglobin &lt; 8.0 mg/dL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>indinavir , HIV , ritonavir , pharmacokinetics , Thailand</keyword>
</DOC>